In other diseases, SLC39A14 upregulation activates NO, a key regulator of the cGMP-PKG pathway, mediating hepatic zinc accumulation and hypozincemia during inflammation and sepsis [70, 71]. This evidence concerns the gene SLC39A14 and Sepsis.